SCHEMBL16223074

SCHEMBL16223074

CCCCc1c(-c2cc3ccccc3o2)nc(N)nc1-c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 1/20 0.42
▸ MAPT P10636 7/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ ADORA2A P29274 3/20 0.40
▸ MAOB P27338 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ STAT1 P42224 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ LMNA P02545 2/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12496138 0.89 GRM4 (0.45) MAPTRAB9ANPC1ALDH1A1MEN1
SCHEMBL21313228 0.84 TLR8 (0.46) MAPTRAB9ANPC1ADORA2AMAOB
SCHEMBL21313270 0.84 MAPT (0.38) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL12495825 0.84 ADK (0.51) ADKMAPTRAB9ANPC1ADORA2A
SCHEMBL21313154 0.84 ADORA2A (0.46) MAPTRAB9ANPC1ADORA2AALDH1A1
SCHEMBL16223029 0.83 MAOB (0.41) MAPTRAB9ANPC1ADORA2AMAOB
SCHEMBL21313146 0.83 ADORA2A (0.44) MAPTRAB9ANPC1ADORA2AMAOB
SCHEMBL21313196 0.81 ADORA2A (0.44) MAPTRAB9ANPC1ADORA2AHPGD
SCHEMBL12495884 0.81 HDAC3 (0.41) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL21313237 0.81 ADORA2A (0.42) MAPTRAB9ANPC1ADORA2AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-B1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I (CZ) 2019-09-04 — — EP claimed
US-8883798-B2 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2014-11-11 — — US claimed
Send feedback